Hepatitis C virus infection and the risk of coronary disease. - Wikidata - awgldk - TriplyDB

Hepatitis C virus infection and the risk of coronary disease.

Hepatitis C virus infection and the risk of coronary disease.

http://www.wikidata.org/entity/Q34802706

about

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer Infectious and coronary artery disease Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus Extrahepatic manifestations of chronic hepatitis C virus infection Hepatitis C virus as a systemic disease: reaching beyond the liver Assessing cardiovascular risk in hepatitis C: An unmet need Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan Cardiovascular disease risk in an aging HIV population: not just a question of biology.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection Hepatitis C treatment completion rates in routine clinical care.Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C Impact of hepatitis C seropositivity on the risk of coronary heart disease events.A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection.Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk.Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients.Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

P2860

Q24197545-67AE8233-97BE-439C-B0B3-0347263681B7 Q26750409-786DE63F-08EF-4921-B87C-D247B94E2075 Q26765245-FC876080-C193-4240-B902-42B5087A8E2D Q26767084-B7C3B631-5569-408C-BA10-FC5393D4519F Q26776387-F954FBD6-F1AB-4C86-88BD-CDD3F4F9AA7B Q26784258-8FEF9512-232B-4861-9815-4D862BEEE56B Q28072257-6E10FBE0-ED9F-4E4D-8E18-EC452EEC8DF4 Q28079826-A9E13B1B-FF6B-45D6-B674-B4B229DD0776 Q28081216-45868205-C1F8-4C28-AE51-9FA05151301B Q30360288-53FEBBBF-DF4F-41ED-9B1B-06A02429A584 Q30360538-85B05CBA-1C3A-4F7D-9FE8-D7C5204CACE0 Q31127335-E8A69B67-9DE7-4247-9F46-7C25DA7F1AFA Q33419423-13C27226-530B-40BA-9AA6-341357469ADA Q33729496-1FCD090B-4EA4-4849-A4A3-3CACF19F7064 Q33877898-D59445DA-D575-43A0-81FB-D784F4DB13F8 Q33982131-0CA99BB0-9B87-4A30-9EBF-66BC30B76089 Q34128534-E5FA9ADA-A197-4291-BC00-E8139B75067D Q34340862-B6DCFA4C-D2CC-41C7-9CA3-8B2B143691E8 Q34712485-A3C88910-7FD0-4FF6-805A-3FCB5E7306CF Q34980383-5F77AF9B-8A70-4E20-93BE-74C60D722361 Q35064091-849DB219-A9C1-46B8-AE9E-E1D578BA9D92 Q35072020-AC0D3844-E213-4DF2-A492-1D236184F303 Q35093134-32661A56-DC9F-4419-8FDA-EC0C9EEDF36D Q35151509-CB740A6E-4413-4B35-91C6-39BA747564AE Q35174850-7ABC0F79-B1A0-4FCD-B628-357A8370D029 Q35214000-0B0CDC61-6B5A-4D58-9156-8E676A65B27B Q35544658-12641691-5337-436C-B616-22510240A630 Q35591469-E4294793-BFAC-45BF-9ECC-7EDC448E56D6 Q35645143-A0EEAEB1-86F4-4FE1-BF6A-6CEE92370808 Q35838417-4D363283-E369-4729-8E9D-ACC013079339 Q35861534-DF0FDBCB-1796-46AB-B5E2-97343000B133 Q35864236-5992BADF-0D04-428C-BD9D-B36A3ED75621 Q35975760-2F23740D-6512-4523-95E9-273D6DA62E7C Q36379566-CD3279C8-E8D6-4810-8C8B-F7C20A9E807E Q36401521-0F83FD8C-9858-4D26-B35B-349B4ABB7C53 Q36419552-DC6734AE-EAF4-498B-BBF5-6596B7AE60D9 Q36497046-C752493F-4D17-486A-8806-B417F811B7D8 Q36723994-C183C92D-2110-47E1-A05F-832BB4F1831B Q36795672-E7ED0ED9-5F10-4B82-8936-540AB9C5551D Q36840571-67128572-D45E-43D3-A08B-2B8D615AC821

P2860

Hepatitis C virus infection and the risk of coronary disease.

http://www.wikidata.org/entity/Q34802706

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatitis C virus infection and the risk of coronary disease.

@ast

Hepatitis C virus infection and the risk of coronary disease.

@en

Hepatitis C virus infection and the risk of coronary disease.

@nl

type

label

Hepatitis C virus infection and the risk of coronary disease.

@ast

Hepatitis C virus infection and the risk of coronary disease.

@en

Hepatitis C virus infection and the risk of coronary disease.

@nl

prefLabel

Hepatitis C virus infection and the risk of coronary disease.

@ast

Hepatitis C virus infection and the risk of coronary disease.

@en

Hepatitis C virus infection and the risk of coronary disease.

@nl

P1433

Q34802706-0231DD59-3271-4411-8028-5D57304AC068

P1476

Q34802706-E03D607B-D80D-4DA6-8711-7E4D31936EE5

P2093

Q34802706-0649C5A6-F891-422C-A72D-8BCCE95B3237

Q34802706-13E80622-9268-488D-9BA9-2C9E1053140F

Q34802706-298FD884-1FEB-484E-BE71-BA2D123B0019

Q34802706-77ABA807-7C86-488A-A0FA-163A99D71F24

Q34802706-7E4AF7E2-D697-4EFD-9E44-7F2E7BBCB9A6

P2860

Q34802706-010BC5AB-75E4-4E33-B8E2-A32E3E0FD586

Q34802706-04E4D686-6B1C-4BC0-8CC0-63788DE77F20

Q34802706-05B42C76-3267-44A3-AD06-BBFAF16E3088

Q34802706-0C436A6F-38FD-4652-BE22-F260098273EB

Q34802706-104FFF49-BC29-4E77-A591-DD90CB66E9C9

Q34802706-187C181C-6BAA-4A0D-803D-51C682FBCA10

Q34802706-23EFFC99-E2AA-478E-9B39-3B49A2798DF1

Q34802706-2FC79B5F-B20C-47BB-9A28-88A58E975182

Q34802706-305CE1E2-0732-4555-86C1-B27A9997AD8C

Q34802706-474A245E-C1A2-4C94-880A-E6D45D3419CA

P304

Q34802706-BC9AA237-B540-4ED9-8854-FD5F0F035C2C

P31

Q34802706-B2FCDE28-3A10-49A7-B3D6-7903784F1F29

P356

Q34802706-800060D2-61F2-4141-99AD-8C5A934CE419

P407

Q34802706-7636D14E-4A52-47DB-BCAE-0CD2C98587FE

P433

Q34802706-01B5278E-9B90-4FF0-80E6-8E4C6395C781

P478

Q34802706-37642E88-47A0-43C7-8BD2-74EB4DF6B9B3

P50

Q34802706-8B4FA753-DE92-4A8B-92DB-3923309FB876

P577

Q34802706-0D131455-F375-4883-B39E-B984956F6B1D

P5875

Q34802706-437994C5-1C63-4DE8-B7D0-A80426D7A8C9

P698

Q34802706-8D9CD48E-3FEE-4AE8-AC3C-75B1645291C5

P932

Q34802706-F0F1A9A3-EAE2-4B41-8402-E42FE356421C

P356

P1433

Clinical Infectious Diseases

P1476

Hepatitis C virus infection and the risk of coronary disease.

@en

P2093

Adeel A Butt

http://www.w3.org/2001/XMLSchema#string

Amy C Justice

http://www.w3.org/2001/XMLSchema#string

David Leaf

http://www.w3.org/2001/XMLSchema#string

Lewis H Kuller

http://www.w3.org/2001/XMLSchema#string

Wang Xiaoqiang

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis

Inflammation, atherosclerosis, and coronary artery disease

Inflammation in atherosclerosis

Comparison of two VA laboratory data repositories indicates that missing data vary despite originating from the same source

Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.

Inflammatory reactions in the pathogenesis of atherosclerosis.

Changes in lipid metabolism in chronic hepatitis C.

Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.

P304

225-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/599371

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Budoff

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26277778

http://www.w3.org/2001/XMLSchema#string

P698

19508169

http://www.w3.org/2001/XMLSchema#string

P932

3077953

http://www.w3.org/2001/XMLSchema#string